{"id":9515,"date":"2025-11-23T12:21:08","date_gmt":"2025-11-23T08:21:08","guid":{"rendered":"https:\/\/medscriptum.org\/?p=9515"},"modified":"2025-11-23T12:21:54","modified_gmt":"2025-11-23T08:21:54","slug":"automated-oxygen-control-in-premature-infants","status":"publish","type":"post","link":"https:\/\/medscriptum.org\/en\/automated-oxygen-control-in-premature-infants\/","title":{"rendered":"Automated Oxygen Control in Premature Infants"},"content":{"rendered":"<p style=\"text-align: justify\" data-path-to-node=\"3\">In the intensive care of premature infants, one of the main clinical dilemmas is the optimal management of oxygen delivery. Although supplementary oxygen is often necessary for survival, this therapy is associated with serious risks: excess oxygen (hyperoxia) causes bronchopulmonary dysplasia and retinopathy, while deficiency (hypoxia) increases the risk of morbidity and mortality. Accordingly, maintaining oxygen levels within a safe range is crucial.<\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"4\">The difficulty lies in the fact that regulating oxygen levels is a complex, labor-intensive, and often inconsistent process. In response to this challenge, a new approach\u2014Closed-Loop Automated Oxygen Control (CLAC) systems\u2014is changing the practice of care for these vulnerable infants. This technology automatically regulates oxygen levels in real-time, significantly improving therapy accuracy, potentially reducing the duration of ventilation and associated complications.<\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"4\"><strong>How Does the CLAC System Work?<\/strong><\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"6\">Closed-Loop Automated Oxygen Control (CLAC) systems combine continuous monitoring with intelligent automation for precise management of oxygen delivery. The process begins with a pulse oximeter that continuously measures peripheral oxygen saturation (SpO2) in real-time.<\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"7\">The system uses advanced algorithms that calculate and determine the necessary concentration of inspired oxygen based on the SpO2 data. Following this, CLAC automatically regulates the fraction of inspired oxygen (FiO2) on respiratory support devices (e.g., high-flow nasal cannulas, ventilators, or CPAP). Thanks to the algorithm parameters, the system quickly and accurately responds to the smallest changes in oxygen levels.<\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"7\"><strong>Study Details:<\/strong><\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"9\"><a href=\"https:\/\/www.mdpi.com\/2227-9067\/12\/11\/1528\" target=\"_blank\" rel=\"noopener\">Several scientific studies<\/a> have compared automated oxygen control with traditional methods. This comparison included both groups of infants: those receiving non-invasive respiratory support (e.g., CPAP or high-flow nasal cannula) and those on mechanical ventilation.<\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"10\">The use of automated (CLAC) systems in prematurely born infants provides the following crucial advantages:<\/p>\n<p style=\"padding-left: 40px;text-align: justify\" data-path-to-node=\"11,0,0\">Improved Oxygen Saturation: CLAC systems increase the duration of time the infant&#8217;s oxygen level is within the safe range by 13-15%.<\/p>\n<p style=\"padding-left: 40px;text-align: justify\" data-path-to-node=\"11,1,0\">Reduced Risk: Episodes of prolonged hypoxia are reduced in infants on CLAC. This directly reduces the risk of developing Bronchopulmonary Dysplasia (BPD), which is common in premature infants.<\/p>\n<p style=\"padding-left: 40px;text-align: justify\" data-path-to-node=\"11,2,0\">Reduced Dependence on Supportive Devices: CLAC systems are associated with a reduction in the duration of ventilation and earlier cessation of supplemental oxygen use.<\/p>\n<p style=\"padding-left: 40px;text-align: justify\" data-path-to-node=\"11,3,0\">Versatility of Use: The system is effective not only for infants on full ventilation but also for those receiving non-invasive respiratory support (e.g., CPAP or high-flow nasal cannula).<\/p>\n<p style=\"padding-left: 40px;text-align: justify\" data-path-to-node=\"11,4,0\">Temporary Adaptation: Some data indicate that in the initial stages of switching to CLAC control, a temporary drop in oxygen (hypoxia) may occur, which quickly normalizes as the infant&#8217;s body adapts.<\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"11,4,0\"><strong>Current Study Limitations<\/strong><\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"13\">Most existing research on CLAC systems has been short-term and caused data heterogeneity due to different protocols. Therefore, long-term clinical outcomes, such as survival rates, impact on neurodevelopment, and others, are still unclear. Accordingly, future research needs to be expanded with larger study samples and longer follow-up periods. Furthermore, proper staff training is essential to achieve the full benefits of CLAC systems.<\/p>\n<p style=\"text-align: justify\" data-path-to-node=\"14\">CLAC systems have significant potential for widespread use, especially as respiratory support evolves toward less invasive methods. Future research will clarify the long-term effect and how to optimally adapt algorithms to the individual clinical needs of each infant.<\/p>\n<p style=\"text-align: justify\">Source: <a href=\"https:\/\/fn.bmj.com\/content\/early\/2025\/11\/10\/archdischild-2025-329022.info\" target=\"_blank\" rel=\"noopener\">bmj<\/a><\/p>\n<p style=\"text-align: justify\"><br style=\"font-weight: 400\" \/><br style=\"font-weight: 400\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the intensive care of premature infants, one of the main clinical dilemmas is the optimal management of oxygen delivery. Although supplementary oxygen is often necessary for survival, this therapy is associated with serious risks: excess oxygen (hyperoxia) causes bronchopulmonary dysplasia and retinopathy, while deficiency (hypoxia) increases the risk of morbidity and mortality. Accordingly, maintaining [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":9516,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1587],"tags":[3025,3026,3027],"class_list":["post-9515","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-clac-system","tag-neonatology","tag-premature-infants"],"acf":[],"_links":{"self":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/9515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/comments?post=9515"}],"version-history":[{"count":1,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/9515\/revisions"}],"predecessor-version":[{"id":9519,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/9515\/revisions\/9519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media\/9516"}],"wp:attachment":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media?parent=9515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/categories?post=9515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/tags?post=9515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}